Literature DB >> 3755127

[Prospective placebo-controlled double-blind study using a bacterial lysate in infections of the respiratory tract and ENT region in children].

U B Schaad, J C Farine, T Fux.   

Abstract

94 children suffering from frequent infections of the respiratory tract and of the ear, nose and throat were treated under double-blind conditions with either a bacterial lysate (n = 45) or a placebo (n = 49). During the 6 months of the trial both treatments brought about a significant decrease in the incidence and duration of these infections as well as in the duration of concomitant antibiotherapy in comparison to the corresponding prior 6-month reference period. As these positive results recorded under the bacterial lysate and the placebo could not be differentiated statistically, the influence of meteorological and epidemiological factors as well as of the age of the children is discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3755127

Source DB:  PubMed          Journal:  Helv Paediatr Acta        ISSN: 0018-022X


  4 in total

Review 1.  Oral purified bacterial extracts in acute respiratory tract infections in childhood: a systematic quantitative review.

Authors:  Claudia Steurer-Stey; Leonie Lagler; Daniel A Straub; Johann Steurer; Lucas M Bachmann
Journal:  Eur J Pediatr       Date:  2006-11-18       Impact factor: 3.183

Review 2.  OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review.

Authors:  Urs B Schaad
Journal:  World J Pediatr       Date:  2010-02-09       Impact factor: 2.764

Review 3.  Antibiotics for prolonged wet cough in children.

Authors:  Julie M Marchant; Helen L Petsky; Peter S Morris; Anne B Chang
Journal:  Cochrane Database Syst Rev       Date:  2018-07-31

4.  Cost-effectiveness analysis of OM-85 vs placebo in the prevention of acute respiratory tract infections (ARTIs) in children that attend day-care centers.

Authors:  Arturo Berber; Blanca Estela Del-Rio-Navarro
Journal:  Health Econ Rev       Date:  2019-05-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.